Vicarious Surgical (RBOT) Set to Announce Earnings on Monday

Vicarious Surgical (NYSE:RBOTGet Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Monday, April 29th. Analysts expect Vicarious Surgical to post earnings of ($0.10) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Vicarious Surgical (NYSE:RBOTGet Free Report) last released its quarterly earnings results on Monday, March 4th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.05. During the same quarter in the prior year, the firm earned ($0.16) EPS. On average, analysts expect Vicarious Surgical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Vicarious Surgical Price Performance

RBOT stock opened at $0.27 on Friday. Vicarious Surgical has a 52-week low of $0.20 and a 52-week high of $2.46. The company has a 50-day moving average of $0.33 and a two-hundred day moving average of $0.37. The stock has a market capitalization of $47.45 million, a price-to-earnings ratio of -0.55 and a beta of 1.18.

Analyst Ratings Changes

Separately, Piper Sandler reduced their target price on shares of Vicarious Surgical from $1.50 to $1.00 and set a “neutral” rating for the company in a research note on Tuesday, March 5th.

Read Our Latest Stock Analysis on RBOT

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

See Also

Earnings History for Vicarious Surgical (NYSE:RBOT)

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.